Impact of Coronary Artery Bypass Graft on left Ventricular Systolic Function

Dilshad Abdulqadir  Rasul; Mohammed Hasan  Alwan

doi:10.56056/amj.2024.234

Authors

Dilshad Abdulqadir Rasul
Mohammed Hasan Alwan

DOI:

https://doi.org/10.56056/amj.2024.234

Keywords:

Coronary artery disease, Coronary artery bypass graft, Left ventricular ejection fraction

Abstract

Background& objective: Coronary artery disease is the common cause of disease-specific mortality and morbidity in Iraq. The objective was to evaluate the effect of coronary artery bypass graft surgery on left ventricular systolic function.

Methods: Present study was an observational prospective study implemented in Surgical Specialty Hospital in Erbil city-Kurdistan region/Iraq through the period of one year from 1^st of June 2021, to 31^st of May 2022 on sample of one hundred and forty patients with ischemic heart diseases underwent coronary artery bypass graft. The ejection fraction of patients was assessed before and after coronary artery bypasses graft surgery.

Results: Mean left ventricular ejection fraction of all patients underwent coronary artery bypass graft was significantly reduced post bypass graft (p=0.01). However, the mean left ventricular ejection fraction for patients with ejection fraction?50% was significantly declined post bypass graft (p<0.001) and for those with ejection fraction <50% was significantly increased post bypass graft (p=0.001), The changes in left ventricular ejection fraction of 139 patients after grafting was distributed into; 34.3% of patients with improved, 21.4% of patients with unchanged and 44.3% of patients with declined, and one patient died.

Conclusions: The left ventricular systolic function following coronary artery bypass graft is dependable on preoperative left ventricular systolic function and it is improved in patients with low ejection fraction, while reduced in patients with normal ejection fraction.

Downloads

Download data is not yet available.

References

Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic of the 20(th) century: coronary heart disease. Am J Med 2014; 127(9):807-12.

Maleki A, Ghanavati R, Montazeri M, Forughi S, Nabatchi B. Prevalence of Coronary Artery Disease and the Associated Risk Factors in the Adult Population of Borujerd City, Iran. J Tehran Heart Cent 2019; 14(1):1-5.

Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes 2019; 12(6):e005375.

Benjamin EJ, Virani SS, Callaway CW, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association. Circulation2018; 137(12):e67-e492.

Cortes-Beringola A, Fitzsimons D, Pelliccia A, Moreno G, Martin Asenjo R, Bueno H. Planning secondary prevention: Room for improvement. Eur J Prev Cardiol 2017; 24 (Suppl 3):22–8.

Amsterdam EA, Wenger NK, BrindisRG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130 (25): 344-26.

Windecker S, Kolh P, Alfonso F, et al; Authors/Task Force members. 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2014; 35 (37):2541–619.

Velazquez EJ, Lee KL, Jones RH, et al; STICHES Investigators. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016; 374(16):1511-20.

Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med 2014; 174(2):223-30.

Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344(8922):563-70.

Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med1986; 314(1):1-6.

Hovnanian AL, Matos Soeiro Ad, Serrano CV et al. Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction. Clinics (Sao Paulo) 2010; 65(1):3-8.

Koene RJ, Kealhofer JV, Adabag S, Vakil K, Viorel G. Florea VG. Effect of coronary artery bypass graft surgery on left ventricular systolic function. J Thorac Dis 2017; 9 (2):262-70.

Papestiev V, Jovev S, Sokarovski M, et al. Changes of Left Ventricular Systolic Function in Patients Undergoing Coronary Artery Bypass Grafting. Open Access Maced J Med Sci 2019; 7(21): Available from: https://doi.org/10.3889/oamjms.2019.849

Khaled S, Kasem E, Fadel A, et al. Left ventricular function outcome after coronary artery bypass grafting, King Abdullah Medical City (KAMC)- single center experience. Egypt Heart J 2019; 71 (1): 2.

Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994; 90 (6):2687–94.

Haxhibeqiri-Karabdic I, Hasanovic A, Kabil E, Straus S. Improvement of ejection fraction after coronary artery bypass grafting surgery in patients with impaired left ventricular function. Med Arch 2014; 68(5):332-4.

Tra?c? SP, Goan?? EV, Târtea GC, Ciurea PL. The Impact of the Risk Factors in the Evolution of the Patients with Left Main Coronary Artery Stenosis Treated with PCI or CABG. Curr Health Sci J 2019; 45(1):19-27.

Deo SV, Sundaram V, Sahadevan J, et al. Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction. J Thorac Cardiovasc Surg. 2021:S0022-5223(21)00132-X.